The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), Johnson & Johnson (Gold) and Lilly (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EHA 2019 | iwCLL: what to expect
Peter Hillmen, MBChB, FRCP, FRCPath, PhD, of the University of Leeds, Leeds, UK, give us an overview of what to expect this September at this year’s iwCLL meeting held in Edinburgh. This interview took place at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.
Transcript
The iwCLL meeting is the biennial meeting of CLL specialists, scientists interested in CLL. So this year, it’s going to be held in Edinburgh in September so we’re expecting probably over 1,000 people interested in CLL at the meeting. The abstracts of, we’ve got a large number of abstracts. It’s a very nice looking program so we’re trying to integrate the
The iwCLL meeting is the biennial meeting of CLL specialists, scientists interested in CLL. So this year, it’s going to be held in Edinburgh in September so we’re expecting probably over 1,000 people interested in CLL at the meeting. The abstracts of, we’ve got a large number of abstracts. It’s a very nice looking program so we’re trying to integrate the biology of CLL with the very rapid changes in treatment in CLL but we’re also including a young investigators’ meeting before the meeting which is always very popular and, for this year, we’re having speakers from around the world, so from Africa, from China, from South America, from India, to get an update to CLL in those countries so that we make it a truly international affair.
Read more...
